HIA was quoted in a Fierce Healthcare article detailing the Drug Enforcement Administration’s (DEA) announcement it will extend telehealth flexibilities that enable clinicians to virtually prescribe controlled medications to their patients through 2024 as it mulls permanent policy changes.
The Health Innovation Alliance signaled that it was disappointed that the DEA did not go further to enact permanent rules.
“While this extension will help millions of Americans access much-needed medications, an extension is not a permanent rule. The DEA needs to stop dragging its feet, admit that tele-prescribing is a success, and trust in the medical professionals who are treating patients,” the organization said in a statement. “Instead of waiting another year and keeping doctors in limbo, the DEA should act with urgency and make tele-prescribing for controlled substances permanent.”